Cochrane · systematic review · CD011159

Mobile phone‐based interventions for improving contraception use

Perinpanathan, T, Maiya, S, van Velthoven, MHHMMT, et al. · Cochrane Database of Systematic Reviews · 2023 · Cochrane Library

Fertility Regulation2 versionsAMSTAR 2: not assessed

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.

Questions

current version

GRADE rated

No studies

Included studies

No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 2 · 100%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Current version only

Summary of findings table ‐ Mobile phone‐based interventions compared to standard of care for improving use of contraception

Population: women users/non‐users of contraception

CD011159.PUB3 (current) · 2 questions

Outcome	Effect	Evidence	Status / GRADE
Contraception use Summary of findings table ‐ Mobile phone‐based interventions vs standard of care	OR 1.3 [1.06, 1.6]	16 studies · 8972 participants	Moderate Downgraded: inconsistency
Pregnancy Summary of findings table ‐ Mobile phone‐based interventions vs standard of care	OR 0.82 [0.48, 1.38]	8 studies · 2947 participants	Moderate Downgraded: imprecision

Comparison

Population: female users or non‐users of contraception

CD011159.PUB2 · 5 questions

Outcome	Effect	Evidence	Status / GRADE
OC use (continuation) at 6 months	RR 1.19 [1.05, 1.35]	683 participants	Low
Effective contraception use at 4 months	RR 1.39 [1.17, 1.66]	431 participants	High
Mean number of missed pills (cycle 1)	Mean difference 0.5	73 participants	Moderate
Contraceptive use during treatment with Isotretinoin at 3 months	RR 1.26 [0.84, 1.89]	108 participants	Very low
Mean number of days between scheduled appointment and completed visit for Depo‐Provera: first visit	no estimate extracted	87 participants	Moderate